Gene therapy for hepatic micrometastasis of murine colon carcinoma

Journal of Hepatology

Volumn 28, Issue 5, 1998, Pages 886-895

  Shiratori, Yasushi ^a,b   Kanai, Fumihiko ^a   Hikiba, Yoko ^b   Moriyama, Hiroshi ^c   Hamada, Hirofumi ^d   Matsumura, Masayuki ^a   Tanaka, Torao ^a   Lan, Keng Hsin ^a   Ohashi, Makoto ^a   Okano, Ken'ichi ^b   Naito, Makoto ^c   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b INSTITUTE FOR ADULT DISEASES   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

^d CANCER INSTITUTE   (Japan)

Author keywords

Gene therapy; Interleukin 2 gene; Metastasis of colon carcinoma; Natural killer (NK) cells; Pit cells

Indexed keywords

INTERLEUKIN 2; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ULTRASTRUCTURE; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; ENHANCER REGION; GENE INDUCTION; GENE THERAPY; KILLER CELL; LIVER METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS RECOMBINATION;

EID: 0032079483     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80240-7     Document Type: Article

References (51)

1. Balabaud C, Sage Ed. Hepatic sinusoidal cells. Semin Liver Dis. 13:1993;1-125.
2. Wisse E, van't Noordende JM, van der Meulen J, Daems WT. The pit cells: description of a new type of cell occurring in rat liver sinusoids and peripheral blood. Cell Tissue Res. 173:1976;423-435.
3. Kaneda K, Wake K. Distribution and morphological characterization of the pit cells in the liver of the rat. Cell Tissue Res. 233:1983;485-505.
4. Bouwens L, Wisse E. Immuno-electron microscopic characterization of large granular lymphocytes (natural killer cells) from rat liver. Eur J Immunol. 17:1987;1423-1428.
5. Wiltrout RH, Mathieson BJ, Talmadge JE, Reynolds CW, Zhang SR, Herberman RB, et al. Augmentation of organ-associated natural killer activity by biological response modifier. J Exp Med. 160:1984;1431-1449.
6. Wiltrout RH, Herberman RB, Zhang SR, Chirigos MA, Ortaldo JR, Green KM, et al. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol. 134:1985;4267-4275.
7. 1-positive cells in the liver. Hepatology. 16:1992;469-478.
8. 1 positive cells from athymic nude or polyinosinic polycytidylic acid-treated mice in suppressing colon-derived experimental hepatic metastasis. Cancer Res. 50:1990;1834-1840.
9. Shiratori Y, Kawase T, Nakata R, Tanaka M, Hikiba Y, Okano K, et al. Effect of splenectomy on hepatic metastasis of colon carcinoma and natural killer activity in the liver. Dig Dis Sci. 40:1995;2398-2406.
10. Kaneda K, Nagamuta M, Kataoka M, Yamamoto H, Kishiye T, Wake K. Ultrastructural characteristics of lymphokine-activated killer cells of the rat in comparison with natural killer cells. Arch Histol Cytol. 54:1991;119-132.
11. Gutierrez AA, Lemoine NR, Sikora K. Gene therapy for cancer. Lancet. 339:1992;715-721.
12. Gore ME, Collins MK. Gene therapy for cancer. Eur J Cancer. 30A:1994;1047-1049.
13. Balkenstein T, Qin Z, Uberla K, Muller W, Rosen H, Volk HD, et al. Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer. J Exp Med. 173:1991;1047-1052.
14. Gansbacher B, Zier K, Daniels B, Cronin K, Bannerji R, Gilboa E. Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med. 172:1990;1217-1224.
15. Nakamura Y, Wakimoto H, Abe J, Kanegae Y, Saito I, Aoyagi M, et al. Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin 2. Cancer Res. 54:1994;5757-5760.
16. Yamada G, Kitamura Y, Sonoda H, Harada H, Taki S, Mulligan RC, et al. Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity. EMBO J. 6:1987;2705-2709.
17. Strauss M. Liver-directed gene therapy: prospective and problems. Gene Ther. 1:1994;156-164.
18. Li Q, Kay MA, Finegold M, Stratford-Perricaudet LD, Woo SLC. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Human Gene Ther. 4:1993;403-409.
19. Jaffe HA, Danel C, Longenecker G, Metzger M, Setoguchi Y, Rosenfeld MA, et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat Genet. 1:1992;372-378.
20. Kass-Eisler A, Falck-Pedersen E, Elfenbein DH, Alvira M, Buttrick PM, Leinwand LA. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1:1994;395-402.
21. Kozarsky K, Wilson JM. Gene therapy: adenovirus vectors. Curr Opin Genet Dev. 3:1993;499-503.
22. Smith KA. Interleukin 2. Ann Rev Immunol. 2:1984;319-333.
23. Zarcone D, Prasthofer EF, Malavasi F, Pistoia V, LoBuglio AF, Grossi CE. Ultrastructural analysis of human natural killer cell activation. Blood. 69:1987;1725-1736.
24. Trinchieri G, Ferussia B. Human natural killer cells: biologic and pathologic aspects. Lab Invest. 50:1984;489-513.
25. Whiteside TL, Heo DS, Takagi S, Johnson JT, Iwatsuki S, Herberman RB. Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2. Cancer Immunol Immunother. 26:1988;1-10.
26. Mule JJ, Yang HC, Arfeniere RL, Shu S, Rosenberg SA. Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2. J Immunol. 139:1987;285-294.
27. Takagi S, Chen K, Schwarz R. Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin-2. Cancer. 63:1989;102-111.
28. Rosenberg SA, Mulle JJ, Spiess PJ, Reichert CM, Schwarz SL. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2. J Exp Med. 161:1985;1169-1188.
29. Timonen T, Gahmberg CG, Patarroyo M. Participation of CD 11a-c/CD18, CD2 and RGD-binding receptors in endogenous and interleukin-2 stimulated NK activity of CD3-negative large granular lymphocytes. Int J Cancer. 46:1990;1035-1040.
30. Anderson TD, Hayers TJ. Toxicity of human recombinant interleukin-2 in rats: pathologic changes are characterized by marked lymphocytic and eosinophilic proliferation and multisystem involvement. Lab Invest. 60:1989;331-346.
31. Fearon ER, Pardoll D, Itaya T, Golumbek P, Levitsky HI, Simons JW, et al. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell. 60:1990;397-403.
32. Chen SS, Chen XHL, Wang Y, Kosai KI, Finegold MJ, Rich SS, et al. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci USA. 92:1995;2577-2581.
33. Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sasaki T, et al. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 23:1995;3816-3821.
34. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, et al. Efficient generation of recombinant adenovirus using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA. 93:1996;1320-1324.
35. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:1991;193-200.
36. Polak JM, McGee JO. In Situ Hybridization. Principles and Practice. 1990;1-247 Oxford University Press, Oxford.
37. Nakane P. In Situ Hybridization (in Japanese). 1992;1-134 Gakusai Kikaku, Tokyo.
38. Koji T, Nakane P. In situ hybridization. Japanese Histochemistry Association edition Histochemistry. 1992;121-134.
39. Isobe Y, Chen ST, Nakane PK, Brown WR. Studies on translocation of immunoglobulins across intestinal epithelium. 1. Improvements in the peroxidase-labeled antibody method for application to study of human intestinal mucosa. Acta Histochem Cytochem. 10:1977;161-171.
40. Freudenberg N, Schalk J, Galanos C, Katschinski T, Datz O, Pein U, et al. Identification and percentage frequency of isolated non-parenchymal liver cells (NPLC) in the mouse. Virchows Arch (B). 57:1989;109-115.
41. Watanabe H, Ohtsuka K, Kimura M, Ikarashi Y, Ohmori K, Kusumi A, et al. Details of an isolation method for hepatic lymphocytes in mice. J Immunol Methods. 146:1992;145-154.
42. Corbett TH, Griswold DP, Roberts BJ, Peckham JC, Schabel FM. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res. 35:1975;2434-2439.
43. Cohen SA, Salazar D, von Muenchhausen W, Werne-Wasik M, Nolan JP. Natural antitumor defense system of the murine liver. J Leukoc Biol. 37:1985;559-569.
44. Matory YL, Chang AE, Lipford EH, Braziel R, Hyatt CL, McDonald HD, et al. Toxicity of recombinant human interleukin-2 in rats following intravenous infusion. J Biol Response Mod. 4:1985;377-390.
45. Bouwen L, Marinelli A, Kuppen PJK, Eggermont AMM, van de Velde CJH, Wisse E. Electron microscopic observations on the accumulation of large granular lymphocytes (Pit cells) and Kupffer cells in the liver of rats treated with continuous infusion of interleukin-2. Hepatology. 12:1990;1365-1370.
46. Tzung SP, Gaines KC, Lance P, Ehrke MJ, Cohen SA. Suppression of hepatic lymphokine-activated killer cell induction by murine Kupffer cells and hepatocytes. Hepatology. 12:1990;644-652.
47. Van den Brink MRM, Palomba ML, Basse PH, Hiserody JC. In situ localization of 3.2.3+ natural killer cells in tissues from normal and tumor-bearing rats. Cancer Res. 51:1991;4931-4936.
48. Schwarz RE, Iwatsuki S, Herberman RB, Whiteside TL. Lymphokine-activated killer cell activity in patients with primary and metastatic malignant liver tumors. Hepatology. 10:1989;221-227.
49. Jonkoski JA, Tzung SP, Doerr RJ, Cohen SA. Hepatic metastasis alters the immune function of murine liver nonparenchymal cells. Arch Surg. 127:1992;1325-1329.
50. Winnock M, Lafon ME, Boulard A, Ferrer AM, Saric J, Dubuisson L, et al. Characterization of liver-associated natural killer cells in patients with liver tumors. Hepatology. 13:1991;676-682.
51. Winnock M, Garcia-Barcina M, Huet S, Bernard P, Saric J, Bioulac-Sage P, et al. Functional characterization of liver-associated lymphocytes in patients with liver metastasis. Gastroenterology. 105:1993;1152-1158.